Skip to main content
Premium Trial:

Request an Annual Quote

Miraculins Hopes to Generate Up to $500K in Equity Placement

NEW YORK (GenomeWeb News) — Miraculins yesterday said it plans to generate as much as $500,000 through a private stock placement.
 
The company plans to use the proceeds to fund research and development projects, and for working capital purposes.
 
Miraculins will offer as many as 1.25 million equity “units” for $.40 apiece. Each unit will include one common company share and one half of one share purchase warrant, which will be set at $.65 for a 12-month period from the date the offering closes.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.